Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AgfiledCriticalSchering Ag
Publication of MX9303555ApublicationCriticalpatent/MX9303555A/en
Se describen derivados de quinoxalina de la fórmula I: (Ver fórmula I); en donde R1 con R2 significa alquilo substituido con de 1 a 12 átomos de carbono, con R2 alquenilo substituido con 3 a 12 átomos de carbono o con R2 -(CH2)n-C6-12-arilo substituido, R4 hidrógeno, con R2alquilo substituido con de 1 a 12 átomos de carbono, con R2 alquenilo substituido con de 3 a 12 átomos de carbono o con R2 -(CH2)n-C6-12-arilo, R5 y R6 son iguales o diferentes y significan hidrógeno, halógeno, nitro, amino, ciano, CF3- alquilo con de 1 a 6 átomos de carbono o alqcoxi con de a átomos de carbono , así como su preparación y su uso en medicamentos.Quinoxaline derivatives of formula I are described: (See formula I); wherein R1 with R2 means alkyl substituted with from 1 to 12 carbon atoms, with R2 alkenyl substituted with 3 to 12 carbon atoms or with R2 - (CH2) n-C6-12-substituted aryl, R4 hydrogen, with R2 substituted alkyl with from 1 to 12 carbon atoms, with R2 alkenyl substituted with from 3 to 12 carbon atoms or with R2 - (CH2) n-C6-12-aryl, R5 and R6 are the same or different and signify hydrogen, halogen, nitro , amino, cyano, CF3-alkyl with from 1 to 6 carbon atoms or alkoxy with from to carbon atoms, as well as their preparation and use in medicines.
MX9303555A1992-07-171993-06-15
DERIVATIVES OF QUINOXALINE, ITS PREPARATION AND USE IN MEDICINES.
MX9303555A
(en)